German drugmaker Boehringer Ingelheim has obtained ad-interim injunctions against four domestic pharmaceutical companies that launched generic versions of Boehringer Ingelheim’s patent-protected drug Linagliptin, which is marketed under the brand...
Pfizer Inc said on Monday it would spend $120 million to boost manufacturing of ...
Zydus Lifesciences Ltd. has received final approval from the United States Food and Drug Administration (USFDA) to market Famotidine tablets in 20 mg and 40 mg strengths (USRLD: Pepcid)...
This World Environment Day, P&G Health reinforced its commitment to sustainable waste management through its new partnership with the Lakshya and Recycle India Foundation for sustainable pharmacy waste segregation and management project as part...
Drug major Sun Pharma plans to increase its field force in the domestic market by 10 per cent in the current fiscal in order to drive twin objectives of brand focus and geographical expansion, according to a senior company official...
Scientists have developed a new type of vaccine that uses a molecule called messenger RNA or mRNA rather than part of an actual virus or bacteria.
After a break of 24 months, the US Food and Drug administration resumed its onsite inspections of drug manufacturing units outside its borders including countries like India
Indian pharmaceutical companies are hiring former US Food and Drug Administration (USFDA) officers to tide over compliance issues. Lupin has hired one such officer, Diana Amador-Toro, as senior vice-president, the company informed shareholders in an
Even as highly effective Covid-19 vaccines have been developed in a year, the history of HIV vaccine research has been far less successful. Experts treating HIV/AIDS have called for using DNA and mRNA based Covid vaccine platforms to successfully...
The National Technical Advisory Group on Immunisation (NTAGI) is likely to review safety and efficacy data of India's first intranasal Covid-19 vaccine by Hyderabad-based Bharat Biotech at a meeting slated for this month. "The firm has approached...